Decline in use of high-risk agents for tight glucose control among older adults with diabetes in New York City: 2017-2022.
Jeff ZhangRania KanchiSarah ConderinoNatalie K LevySamrachana AdhikariSaul BleckerNichola DavisJasmin DiversCatherine RabinMark WeinerLorna ThorpeJohn A DodsonPublished in: Journal of the American Geriatrics Society (2024)
We found an encouraging trend toward less use of high-risk medication strategies for older adults with type 2 diabetes and multiple chronic conditions. However, one in six patients in 2022 still had inappropriate tight glycemic control, indicating a need for continued efforts to optimize diabetes management in this population.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- end stage renal disease
- cardiovascular disease
- blood brain barrier
- weight loss
- ejection fraction
- chronic kidney disease
- newly diagnosed
- healthcare
- prognostic factors
- insulin resistance
- peritoneal dialysis
- physical activity
- blood pressure
- patient reported outcomes
- adverse drug
- patient reported